Biocon inks license, supply pact with CMS for 3 generic formulations Medical Dialogues Bureau13 Sep 2019 9:15 AM GMTUnder the terms of the agreement, Biocon will be responsible for the development, manufacturing and supply of the products and China Medical System...
Sun Pharma enters licensing agreement with CMS for arthritis drug Tildrakizumab Medical Dialogues Bureau28 Jun 2019 7:00 AM GMTThe initial tenure of the agreement between Sun Pharma and CMS shall be 15 years from the first commercial sale of Tildrakizumab in Greater China and...
Medicare hospital fund reserves likely to be exhausted in 2026: US report Medical Dialogues Bureau23 April 2019 3:30 AM GMTThe report from the board of trustees for Social Security and Medicare also projected that Social Security funds could be depleted by 2035, leading to...